COIL — Coiled Therapeutics Share News
0.000.00%
Roquefort Theraptcs. - Director/PDMR Shareholding
Roquefort Theraptcs. - Director/PDMR Shareholding
Roquefort Theraptcs. - Notice of Annual General Meeting
Roquefort Theraptcs. - Annual Report & Financial Statements - 31 Dec 2022
Brief: Roquefort Therapeutics PLC Says Suspension Of Trading Pending 2022 Annual Report
Brief: Roquefort Therapeutics Announces Development Of New Novel Platform Of Anti-Cancer Mrna Therapeutics
Roquefort Theraptcs. - Formation of Scientific Advisory Board
RCS - Roquefort Theraptcs. - Company Presentation
RCS - Roquefort Theraptcs. - Investor Presentation
UK's Roquefort Therapeutics gains on licence deal with Randox Labs
Brief: Roquefort Therapeutics Signs Exclusive Licence And Royalty Agreement With Randox Laboratories
Roquefort Theraptcs. - Randox Licence and Royalty Agreement
Brief: Roquefort Therapeutics Says MDK Oncology Antibodies Demonstrate In-Vivo Safety
Brief: Roquefort Investments Says MDK Oncology Antibodies Demonstrate In-Vivo Safety
Roquefort Theraptcs. - MDK Oncology Antibodies Demonstrate In-Vivo Safety
Roquefort Theraptcs. - Holding(s) in Company
Roquefort Theraptcs. - Appointment of Auditor
Roquefort Theraptcs. - Operations Update
RCS - Roquefort Theraptcs. - Presentation of Midkine Oligonucleotide Program